Abstract According to the World Health Organisation, as of October 2022, there have been
55,560,329 reported cases of SARS‐COV‐2 in patients under 19 years old. It is estimated …

Background and objective The most important presentation of COVID-19 is hyper
inflammatory condition and cytokine storm that occurs due to excessive increase of the …

Background A severe multisystem inflammatory syndrome in children (MIS-C) related to
SARS-CoV-2 has been described after infection. A limited number of reports have analyzed …

Objective In this study, it was aimed to evaluate the demographic, clinical and laboratory
characteristics of MIS-C patients in our hospital, to share our treatment approach, and to …

Background Few single center studies from resource-poor settings have reported about the
epidemiology, clinical feature and outcome of multisystem inflammatory syndrome in …

Multisystem inflammatory syndrome in children (MIS-C) is a dysregulated autoimmune-
mediated illness in genetically susceptible patients following COVID-19 with an interval of 2 …

Background Pediatric multisystem inflammatory syndrome temporally associated with
COVID-19 (PIMS-TS) is a serious complication of a previous SARS-CoV-2 infection in the …

Studies on the severity in multisystem inflammatory syndrome in children (MIS-C) show
heterogeneous results and may not reflect a global perspective. This systematic review aims …

Multisystem inflammatory syndrome in children (MIS-C) has been widely reported in some
children diagnosed with SARS-CoV-2. Clinical signs of MIS-C are manifested at 2 to 4 …

Der COVID-19-mRNA-Impfstoff Comirnaty ist in Europa seit dem 25.11. 2021 mit einer
reduzierten Impfstoffdosis (10 μg) für die Impfung gegen COVID-19 von Kindern im Alter von …